Class I MHC presentation of exogenous antigens

Journal of Clinical Immunology

Volumn 16, Issue 2, 1996, Pages 90-96

  Harding, Clifford V ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Antigen processing; Class I MHC; Phagolysosome

Indexed keywords

HEAT SHOCK PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN PRESENTATION; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PHAGOSOME; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; CELL COMPARTMENTATION; HEAT-SHOCK PROTEINS; HISTOCOMPATIBILITY ANTIGENS CLASS I; PROTEIN BINDING; T-LYMPHOCYTES;

EID: 0030007165     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01540955     Document Type: Review

References (50)

1. Harding CV, Geuze HJ: Antigen processing and intracellular traffic of antigens and MHC molecules. Curr Opin Cell Biol 5:596-605, 1993
2. Attaya M, Jameson S, Martinex CK, Hermel E, Aldrich C, Forman J, Lindahl KF, Bevan MJ, Monaco JJ: Ham-2 corrects the class I antigen-processing defect in RMA-S cells. Nature 355:647-649, 1992
3. Kelly A, Powis SJ, Derr L-A, Mockridge I, Elliott T, Bastin J, Uchanska-Ziegler B, Ziegler A, Trowsdale J, Townsend A: Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex. Nature 355:641-644, 1992
4. Spies T, Cerundolo V, Colonna M, Cresswell P, Townsend A, DeMars R: Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer. Nature 355:644-646, 1992
5. Shepherd JC, Schumacher TNM, Ashton-Rickardt PG, Imaeda S, Ploegh JL, Janeway CAJ, Tonegawa S: TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective. Cell 74:577-584, 1993
6. Van Kaer L, Aston-Rickardt PG, Ploegh HL, Tonegawa S: TAP1 mutant mice are deficient in antigen presentation, surface class I molecules and CD4-8+ T cells. Cell 71:1205-1214, 1992
7. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D, Goldberg AL: Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761-771, 1994
8. Harding CV, France J, Song R, Farah JM, Chatterjee S, Iqbal M, Siman R: Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen processing pathway. J Immunol 155: 1767-1755, 1995
9. Bevan MJ: Cross-priming for a secondary response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med 143:1283-1288, 1976
10. Gooding LR, Edwards CB: H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic T lymphocytes. J Immunol 124:1258-1262, 1980
11. Jin Y, Shin WK, Berkower I: Human T cell response to the surface antigen of hepatitis B virus (HBsAg). Endosomal and nonendosomal processing pathways are accessible to both endogenous and exogenous antigen. J Exp Med 168:293-306, 1988
12. Carbone FR, Bevan MJ: Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J Exp Med 171:377-387, 1990
13. Debrick JE, Campbell PA, Staerz UD: Macrophages as accessory cells for class I MHC-restricted immune responses. J Immunol 147:2846-2851, 1991
14. Collins DS, Findlay K, Harding CV: Processing of exogenous liposome-encapsulated antigens in vivo generates class I MHC-restricted T cell responses. J Immunol 148:3336-3341, 1992
15. Zhou F, Rouse BT, Huang L: Induction of cytotoxic T lymphocytes in vivo with protein antigen entrapped in membranous vehicles. J Immunol 149:1599-1604, 1992
16. Pfeifer JD, Wick MJ, Roberts RL, Findlay KF, Normark SJ, Harding CV: Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361:359-362, 1993
17. Harding CV, Song R: Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J Immunol 53:4925-4933, 1994
18. Kovacsovics-Bankowski M, Rock KL: A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267:243-246, 1995
19. Liu T, Zhou X, Örvell C, Lederer E, Ljunggren H-G, Jondal M: Heat-inactivated Sendai virus can enter multiple MHC class I processing pathways and generate cytotoxic T lymphocyte responses in vivo. J Immunol 154:3147-3155, 1995
20. Schirmbeck R, Melber K, Reimann J: Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation. Eur J Immunol 25:1063-1070, 1995
21. Bachmann MF, Oxenius A, Pircher H, Hengartner H, AshtonRichardt PA, Tonegawa S, Zinkernagel RM: TAP1-independent loading of class I molecules by exogenous viral proteins. Eur J Immunol 25:1739-1743, 1995
22. De Bruijn MLH, Jackson MR, Peterson PA: Phagocyte-induced antigen-specific activation of unpromed CD8+ T cells in vitro. Eur J Immunol 25:1274-1285, 1995
23. Reis e Sousa C, Germain R: Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J Exp Med 182:841-851, 1995
24. Zhou X, Glas R, Liu T, Ljunggren H-G, Jondal M: Antigen processing mutant T2 cells present viral antigen restricted through H-2Kb. Eur J Immunol 23:1802-1808, 1993
25. Kovacsovics-Bankowski M, Clark K, Benacerraf B, Rock KL: Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc Natl Acad Sci USA 90:4942-4946, 1993
26. Bevan MJ: Antigen presentation to cytotoxic T lymphocytes in vivo. J Exp Med 182:639-641, 1995
27. + T cells in resistance to cutaneous leishmaniasis in immunized mice. J Immunol 142:2052-2056, 1989
28. Denkers EY, Gazzinelli RT, Hieny S, Caspar P, Sher A: Bone marrow macrophages process exogenous Toxoplasma gondii polypeptides for recognition by parasite-specific cytolytic T lymphocytes. J Immunol 150:517-526, 1993
29. Flynn JL, Weiss WR, Norris KA, Siefert HS, Kumar S, So M: Generation of a cytotoxic T-lymphocyte response using a Salmonella antigen-delivery system. Mol Microbiol 4:2111-2118, 1990
30. + cytotoxic T cells. J Exp Med 172:1083-1090, 1990
31. Turner SJ, Carbone FR, Strugnell RA: Salmonella typhimurium delta aroA delta aroD mutants expressing a foreign recombinant protein induce specific major histocompatibility complex class I-restricted cytotoxic T lymphocytes in mice. Infect Immun 61: 5374-5380, 1993
32. Schirmbeck R, Reimann J: Peptide transporter-independent, stress protein-mediated endosomal processing of endogenous protein antigens for major histocompatibility complex class I presentation. Eur J Immunol 24:1478-1486, 1994
33. + T cells requires secretion of hemolysin and intracellular bacterial growth. J Immunol 145:3540-3546, 1990
34. Yewdell JW, Bennink JR, Hosaka Y: Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. Science 239:637-640, 1988
35. Unanue ER, Harding CV, Luescher IF, Roof RW: Antigen-binding function of class II MHC molecules. CSH Symp Quant Biol 54:383-391, 1989
36. Wick MJ, Pfeiler JD, Findlay KA, Harding CV, Normark SJ: Compartmentalization of defined epitopes expressed in Escherichia coli has only a minor influence on efficiency of phagocytic processing for presentation by class I and class II major histocompatibility complex molecules to T cells. Infect Immun 61:4848-4856, 1993
37. + cytotoxic T lymphocyte responses in vivo. J Immunol 152:1110-1119, 1994
38. Schirmbeck R, Melber K, Mertens T, Reiman J: Selective stimulation of murine cytotoxic T cell and antibody responses by particulate or monomeric hepatitis B virus surface (S) antigen. Eur J Immunol 24:1088-1096, 1994
39. Böhm W, Schirmbeck R, Elbe A, K. M, Diminky D, Kraal G, Van Rooijen N, Barenholz Y, Reimann J: Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo. J Immunol 155:3313-3321, 1995
40. Schirmbeck R, Böhm W, Melber K, Reimann J: Processing of exogenous heat-aggregated (denatured) and particulate (native) hepatitis B surface antigen for class I-restricted epitope presentation. J Immunol 155:4676-4684, 1995
41. Song R, Harding CV: submitted 1996
42. Day PM, Esquivel F, Lukszo J, Bennink JR, Yewdell JW: Effect of TAP on the generation and intracellular trafficking of peptide-receptive major histocompatibility complex class I molecules. Immunity 2:137-147, 1995
43. Udono H, Srivastava PK: Comparison of tumor-specific immunogenicities of stress-induced proteins Gp96, Hsp90 and Hsp70. J Immunol 152:5398-5403, 1994
44. Arnold D, Raath S, Rammensee H-G, Schild H: Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J Exp Med 182:885-889, 1995
45. Udono H, Srivastava PK: Heat shock protein 70-associated peptides elicit specific cancer immunity. J Exp Med 178:1391-1396, 1993
46. Udono H, Levey DL, Srivastava PK: Cellular requirements for tumor-specific immunity elicited by heat-shock proteins. Tumor rejection antigen-Gp96 primes CD8+ T cells in vivo. Proc Natl Acad Sci USA 91:3077-3081, 1994
47. Srivastava PK, Udono H, Blachere NE, Li ZH: Heat-shock proteins transfer peptides during antigen-processing and CTL priming. Immunogenetics 39:93-98, 1994
48. Suto R, Srivastava PK: A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 269: 1585-1588, 1995
49. Harding CV, Pfeifer JD: Antigen expressed by Salmonella typhimurium is processed for class I major histocompatibility complex presentation by macrophages but not infected epithelial cells. Immunology 83:670-674, 1994
50. Harding CV: Phagocytic processing of antigens for presentation by MHC molecules. Trends Cell Biol 5:105-109, 1995